Trial intelligence / Profile preview

Effect of PENG Block on Postoperative Delirium in Older Adults Undergoing Total Hip Arthroplasty

NCT07449468Recruiting

Sponsor
Poznan University of Medical Sciences
Start
Mar 2026
Primary completion
May 2027
Modality
Orthosteric Ligands
Countries
1
01

Overview

Randomised, single-blind trial of ropivacaine in postoperative delirium (POD) (2 arms), sponsored by Poznan University of Medical Sciences. Primary endpoint: Incidence of Postoperative Delirium at 72 hours. Started Mar 2026; status: recruiting.

02

Drugs

ropivacaine
03

Conditions

postoperative delirium (POD)

Beyond the preview

Go deeper on NCT07449468.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT07449468.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call